Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
CXSL2300816 | 重组人源抗狂犬病病毒单克隆抗体注射液 | Injection | Biological Products(1) | New Drug Application | 2023-11-28 | Lanzhou Institute of Biological Products Co Ltd | view | ||||
CXSL2300479 | 重组人源抗狂犬病病毒单克隆抗体注射液 | Injection | Biological Products(1) | New Drug Application | 2023-07-14 | Lanzhou Institute of Biological Products Co Ltd | view |